Eligard

Active ingredient
Leuprorelinacetat
Pharma Company
Astellas Pharma GmbH
Total Number of Doctors1
23 doctors
Total Number of Patients2
2,767 patients
Total minimum fees planned3
900,050.00 €

Observational Studies including Eligard

Drug No. of doctors1 No. of patients2 Payment per patient3
Eligard n/a 800 250.00 € gesamt bei vollständiger Dokumentation
Eligard 45mg n/a 300 500.00 € pro vollständiger Dokumentation der Patientendaten
Eligard 23 400 900.00 € 150,- Euro Eingangsvisite, jeweils 50,-- Euro für alle nachfolgenden Visiten (15 über 4 Jahre)
Eligard 45 mg n/a 1,267 150.00 € pro vollständigen dokumentierten Fallbericht
Eligard 22,5 mg n/a n/a 150.00 € pro vollständig dokumentiertem Fallbericht
Eligard 45 mg n/a n/a 150.00 € pro vollständigen dokumentierten Fallbericht

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.